NCT03712891View on ClinicalTrials.gov

Evaluation of Providing Coffee to Patients Postoperatively to Decrease Length of Stay in the PACU

NACompletedINTERVENTIONAL

Enrollment

178

Participants

Timeline

Start Date

October 25, 2018

Primary Completion Date

July 1, 2023

Study Completion Date

August 16, 2023

Conditions

PACU Length of StayPostoperative NauseaPostoperative VomitingPatient Satisfaction

Interventions

DIETARY_SUPPLEMENT

Coffee

Patients will receive coffee in a Styrofoam cup at a temperature of 125 degree Fahrenheit or less. Coffee will be offered to the patient in the PACU once the patient's gag reflex has been restored following their procedure. Volume of estimated coffee consumption will be measured using a sample scale (with a maximum of 300mL of coffee offered)

Trial Locations (1)

45242

Bethesda North Hospital, Cincinnati

All Listed Sponsors

lead

TriHealth Inc.

OTHER

NCT03712891 - Evaluation of Providing Coffee to Patients Postoperatively to Decrease Length of Stay in the PACU | Biotech Hunter | Biotech Hunter